Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01669395
Other study ID # H-2-2012-021
Secondary ID
Status Not yet recruiting
Phase N/A
First received August 14, 2012
Last updated August 16, 2012
Start date September 2012
Est. completion date July 2016

Study information

Verified date August 2012
Source University Hospital, Gentofte, Copenhagen
Contact Laura Staun Valentiner, Master in health scien
Phone + 45 39 77 39 51
Email laura.risted.staun.valentiner@regionh.dk
Is FDA regulated No
Health authority Denmark: Danish Health and Medicines Authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effect of an early, coordinated rehabilitation intervention for patients with severe heart failure in NYHA class III and IV with a ejection fraction of <40% of normal cardiac function measured on frequency of readmissions, physical ability and participation in activities of daily living and quality of life.


Description:

Approximately 400,000 Danes live today with heart disease. Disease severity is crucial for patients quality of life. Patients with severe heart disease often struggle with everyday life, characterized by reduced physical capacity, tendency to depression and anxiety to perform everyday activities that may provoke symptoms.

A large proportion of patients who are offered cardiac rehabilitation deselect that offer. Of the patients who do participate, more than 50% stop the rehabilitation ahead of time. A large group of patients with severe heart failure and classified in NYHA Class III and IV, deselect the offer because of lack of energy to participate in cardiac rehabilitation or is when specified by a medical assessment discharged from the hospital without the offer of training or any other form of rehabilitation.

The offer of rehabilitation for patients with severe heart failure is lacking as it is today. This study assesses the effectiveness of an early home based rehabilitation program that complements the general psycho-social support, symptom-oriented and preventive medical treatment that these patients always have the option to get.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date July 2016
Est. primary completion date September 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients admitted to the Gentofte Hospital due to heart failure.

- Patients with a functional equivalent to NYHA grade III or IV

- Patients with ejection fraction <40%

- Patients who score between10-15 in the total score for question 3 dealing with physical functioning in SF-36 questionnaire on health status

- Patients who lives in Gentofte Municipality or Lyngby Tårbæk Municipality.

- Patients who can speak and understand Danish

Exclusion Criteria:

- Patients with cognitive and psychological problems that prevents cooperation (aphasia, dementia, severe depression).

- Patients with terminal illness with expected death within a year.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Intervention

Other:
Early homebased rehabilitation after hospital admission
Training begins 3-5 days after discharge from hospital, performed by an occupational therapist and a physiotherapist from Gentofte Hospital in the first two weeks. From week three to six the training will be carried out by an occupational therapist and a physiotherapist from the local municipality (Gentofte municipality and Lyngby Taarbæk municipality). Training will take place at home twice a week for 6 weeks, each session lasting 45 minutes. The intervention is individualized and focuses on functional physical and compensatory training to help the patient to manage everyday life at home. A training program will be provided and the patient will be instructed to do the exercises every day
Usual care
After discharge from the hospital the patients are offered the usual symptom-oriented and preventive medical care and psychosocial support

Locations

Country Name City State
Denmark Department of Occupational Therapy and Physiotherapy, Copenhagen University Hospital Gentofte, Copenhagen Gentofte

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Gentofte, Copenhagen

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Readmission due to heart failure assessed one year after inclusion No
Secondary Physical capacity measured by the Morton Mobility Index, Timed Up & Go and Modified Sit to Stand Test Assessed at baseline, after 6 weeks, after 6 month and after one year No
Secondary Activity of Daily Living Recorded at an ADL interview to assess the performance of everyday activities Assessed at baseline, after 6 weeks, after 6 month and after one year No
Secondary Number of total hospital admissions at baseline, after 6 weeks, after 6 month and after one year No
Secondary Exercise Compliance registration of exercise at baseline, after 6 weeks, after 6 month and after one year No
Secondary Anxiety and depression measured by Hospital Anxiety and Depression Scale (HAD) at baseline, after 6 weeks, after 6 month and after one year No
Secondary Quality of life measured by The Minnesota Living with Heart Failure Questionnaire at baseline, after 6 weeks, after 6 month and after one year No
Secondary Number of patients who starts outpatient cardiac rehabilitation after intervention (municipality or hospital) at 6 weeks, after 6 month and after one year No
See also
  Status Clinical Trial Phase
Completed NCT03597646 - The Effect of Kinesio Taping on Pulmonary Function and Functional Capacity in Patients With Chronic Heart Failure N/A
Terminated NCT04065997 - Apogee International
Withdrawn NCT03675113 - Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure N/A
Completed NCT02916160 - Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study Phase 4
Completed NCT03126656 - Effects of Testosterone on Myocardial Repolarization Phase 4
Completed NCT02268500 - VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT) Phase 4
Completed NCT02247245 - The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients. N/A
Completed NCT01919918 - Muscle Afferent Feedback Effects in Patients With Heart Failure Phase 1
Terminated NCT01906957 - Cognition and Exercise Training N/A
Completed NCT00984529 - Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia N/A
Recruiting NCT00863421 - Sleep Disordered Breathing in Patients With Chronic Heart Failure N/A
Completed NCT02840565 - Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453 Phase 1
Completed NCT02441218 - Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study Phase 3
Completed NCT00149409 - Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure Phase 2/Phase 3
Terminated NCT05532046 - A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT) Phase 1
Recruiting NCT04984928 - Readmission Risk of Patients With Heart Failure.
Completed NCT02814097 - A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction Phase 2
Active, not recruiting NCT05560737 - ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
Recruiting NCT03286127 - Palliative Outcome Evaluation Muenster I
Not yet recruiting NCT06002321 - Right Ventricular Dysfunction in Chronic Heart Failure